These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36380412)

  • 1. Vaccines: An Important Tool for Infectious Disease.
    Saman S; Chauhan I; Srivastava N
    Recent Adv Antiinfect Drug Discov; 2023; 18(2):88-109. PubMed ID: 36380412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel approaches to vaccine delivery.
    O'Hagan DT; Rappuoli R
    Pharm Res; 2004 Sep; 21(9):1519-30. PubMed ID: 15497674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel approaches to pediatric vaccine delivery.
    O'Hagan DT; Rappuoli R
    Adv Drug Deliv Rev; 2006 Apr; 58(1):29-51. PubMed ID: 16480788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging skin-targeted drug delivery strategies to engineer immunity: A focus on infectious diseases.
    Korkmaz E; Balmert SC; Carey CD; Erdos G; Falo LD
    Expert Opin Drug Deliv; 2021 Feb; 18(2):151-167. PubMed ID: 32924651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging adjuvants for intradermal vaccination.
    Chen X
    Int J Pharm; 2023 Feb; 632():122559. PubMed ID: 36586639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral vaccination using microdevices to deliver α-GalCer adjuvanted vaccine afford a mucosal immune response.
    Carlsen PHR; Kjeldsen RB; Pedersen GK; Christensen D; Nielsen LH; Boisen A
    J Control Release; 2023 Jan; 353():134-146. PubMed ID: 36372387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Needle-free vaccine delivery.
    Giudice EL; Campbell JD
    Adv Drug Deliv Rev; 2006 Apr; 58(1):68-89. PubMed ID: 16564111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine adjuvants: current challenges and future approaches.
    Wilson-Welder JH; Torres MP; Kipper MJ; Mallapragada SK; Wannemuehler MJ; Narasimhan B
    J Pharm Sci; 2009 Apr; 98(4):1278-316. PubMed ID: 18704954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in respiratory immunization: A focus on COVID-19 vaccines.
    He X; Chen X; Wang H; Du G; Sun X
    J Control Release; 2023 Mar; 355():655-674. PubMed ID: 36787821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chrysanthemum sporopollenin: A novel vaccine delivery system for nasal mucosal immunity.
    Liu J; Yan XD; Li XQ; Du YH; Zhu LL; Ye TT; Cao ZY; Dong ZW; Li ST; Xu X; Bai W; Li D; Zhang JW; Wang SJ; Li SH; Sun J; Yin XZ
    Front Immunol; 2023; 14():1132129. PubMed ID: 36845130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled delivery of antigens and adjuvants in vaccine development.
    Zhao Z; Leong KW
    J Pharm Sci; 1996 Dec; 85(12):1261-70. PubMed ID: 8961136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational application of nanoadjuvant for mucosal vaccine delivery system.
    Dewangan HK
    J Immunol Methods; 2020; 481-482():112791. PubMed ID: 32387695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prime-Pull Immunization with a Bivalent M-Protein and Spy-CEP Peptide Vaccine Adjuvanted with CAF®01 Liposomes Induces Both Mucosal and Peripheral Protection from
    Ozberk V; Reynolds S; Huo Y; Calcutt A; Eskandari S; Dooley J; Mills JL; Rasmussen IS; Dietrich J; Pandey M; Good MF
    mBio; 2021 Feb; 12(1):. PubMed ID: 33622722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New-age vaccine adjuvants, their development, and future perspective.
    Verma SK; Mahajan P; Singh NK; Gupta A; Aggarwal R; Rappuoli R; Johri AK
    Front Immunol; 2023; 14():1043109. PubMed ID: 36911719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal Vaccine Development Based on Liposome Technology.
    Bernasconi V; Norling K; Bally M; Höök F; Lycke NY
    J Immunol Res; 2016; 2016():5482087. PubMed ID: 28127567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of vaccine adjuvanticity at mucosal surfaces.
    Foss DL; Murtaugh MP
    Anim Health Res Rev; 2000 Jun; 1(1):3-24. PubMed ID: 11706842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intradermal delivery of a quadrivalent cell-based seasonal influenza vaccine using an adjuvanted skin patch vaccination platform.
    Ellison TJ; Talbott GC; Henderson DR
    Vaccine; 2023 Jan; 41(2):304-314. PubMed ID: 36587961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biocompatible Mater Constructed Microneedle Arrays as a Novel Vaccine Adjuvant- Delivery System for Cutaneous and Mucosal Vaccination.
    Wang T; Wang N
    Curr Pharm Des; 2015; 21(36):5245-55. PubMed ID: 26412356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adjuvant effect of bacterium-like particles depends on the route of administration.
    Sudo H; Tokunoh N; Tsujii A; Kawashima S; Hayakawa Y; Fukushima H; Takahashi K; Koshizuka T; Inoue N
    Front Immunol; 2023; 14():1082273. PubMed ID: 36742329
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.